Imunon Inc (IMNN)
1.40
-0.01
(-0.71%)
USD |
NASDAQ |
May 16, 16:00
1.39
-0.01
(-0.71%)
After-Hours: 20:00
Imunon Cash from Financing (Quarterly): 0.0302M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0302M |
| September 30, 2023 | 0.0783M |
| June 30, 2023 | -6.221M |
| March 31, 2023 | 2.474M |
| December 31, 2022 | 0.4473M |
| September 30, 2022 | -0.064M |
| June 30, 2022 | 6.339M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.0083M |
| June 30, 2021 | 14.32M |
| March 31, 2021 | 40.46M |
| December 31, 2020 | 2.561M |
| September 30, 2020 | -3.132M |
| June 30, 2020 | 12.76M |
| March 31, 2020 | 5.795M |
| December 31, 2019 | 1.669M |
| September 30, 2019 | 1.712M |
| June 30, 2019 | 2.709M |
| March 31, 2019 | 1.755M |
| December 31, 2018 | -0.3781M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 9.725M |
| March 31, 2018 | 1.237M |
| December 31, 2017 | 25.72M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.163M |
| June 30, 2017 | 3.256M |
| March 31, 2017 | 3.316M |
| December 31, 2016 | 0.2781M |
| September 30, 2016 | -1.040M |
| June 30, 2016 | 4.428M |
| March 31, 2016 | -0.9885M |
| December 31, 2015 | -0.3799M |
| September 30, 2015 | -1.011M |
| June 30, 2015 | 6.352M |
| March 31, 2015 | -0.8784M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 4.964M |
| March 31, 2014 | 13.81M |
| December 31, 2013 | 0.478M |
| September 30, 2013 | -0.4702M |
| June 30, 2013 | 8.599M |
| March 31, 2013 | 20.78M |
| December 31, 2012 | 6.873M |
| September 30, 2012 | 3.876M |
| June 30, 2012 | 4.817M |
| March 31, 2012 | -0.0463M |
| December 31, 2011 | 13.94M |
| September 30, 2011 | 23.37M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-6.221M
Minimum
Jun 2023
40.46M
Maximum
Mar 2021
4.312M
Average
1.669M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 0.001M |
| iBio Inc | 4.005M |
| Ocugen Inc | -0.145M |
| Petros Pharmaceuticals Inc | -2.373M |
| Moderna Inc | 14.00M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.772M |
| Cash from Investing (Quarterly) | -3.304M |
| Free Cash Flow | -19.47M |
| Free Cash Flow Per Share (Quarterly) | -0.4012 |
| Free Cash Flow Yield | -153.7% |